Neuphoria Therapeutics Inc. (NEUP)

Profile

Full Name

Neuphoria Therapeutics Inc.

Ticker

NASDAQ: NEUP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 16, 2021

Indexes

Not included

Website

https://www.neuphoriatx.com

Employees

8

Key Details

Price

$4.97(1.55%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$15.65M(100.00% YoY)

Annual EPS

-$0.23(77.59% YoY)

PE Ratio

-

Next earnings date

Nov 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $4.97
    NEUP price is $4.97

    30-Day Relative Volume

    0.72
    NEUP 30-day relative volume is 0.72

    Price Performance

    Price 1-Day Change

    +1.55%
    NEUP price is up +1.55% today

    Price YTD Change

    +44.77%
    NEUP price is up +44.77% since January 1st

    Price 1-Year Change

    +30.54%
    NEUP price is up +30.54% year-on-year

    Price 3-Year Change

    -95.22%
    NEUP price is down -95.22% over the past 3 years

    Price Range

    Price All-Time High

    $264.00
    NEUP price is currently -98.12% below its historical high of $264.00

    Price 3-Year Low

    $2.12
    NEUP price is currently +133.79% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $9.34M
    NEUP market cap is $9.34 million

    Market Cap 3-Year Change

    -99.99%
    NEUP market cap is down -99.99% over the past 3 years

    Market Cap All-Time High

    $210.64B
    NEUP market cap is currently -100.00% below its historical high of $210.64 billion

    Market Cap Sector Percentile

    16.3%
    NEUP market cap is higher than 16.3% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -99.36%
    NEUP shares outstanding is down -99.36% year-on-year

    Shares Outstanding 3-Year Change

    -99.86%
    NEUP shares outstanding is down -99.86% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.10
    NEUP beta is 1.10

    200-day SMA

    $7.45
    NEUP price is currently -33.38% below its 200-day simple moving average

    50-day SMA

    $11.05
    NEUP price is currently -55.05% below its 50-day simple moving average

    14-Day RSI

    36.53
    NEUP 14-day relative strength index is 36.53

    Volume

    0.72
    NEUP 30-day relative volume is 0.72

    ATR

    $1.30
    NEUP average true range is $1.30

    10-day Historical Volatility

    116.24%
    NEUP 10-day historical volatility is 116.24%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $15.65M
    NEUP annual revenue is $15.65 million

    Revenue Analysts Estimate

    -
    NEUP annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    +100%
    NEUP annual revenue is up +100% year-on-year

    Revenue Sector Percentile

    51.6%
    NEUP annual revenue is higher than 51.6% of companies in Healthcare sector

    EPS

    EPS

    -$0.23
    NEUP annual earnings per share is -$0.23

    EPS Analysts Estimate

    -$5.26
    NEUP annual earnings per share is currently +95.67% higher than the consensus analysts' forecast

    EPS 1-Year Change

    +77.59%
    NEUP annual earnings per share is up +77.59% year-on-year

    EPS Sector Percentile

    74.58%
    NEUP annual earnings per share is higher than 74.58% of companies in Healthcare sector

    Profit

    Gross Profit

    $14.99M
    NEUP annual gross profit is $14.99 million

    Gross Margin

    95.76%
    NEUP annual gross profit margin is 95.76%

    Operating Profit

    -$1.13M
    NEUP annual operating income is -$1.13 million

    Operating Margin

    -7.22%
    NEUP annual operating profit margin is -7.22%

    Net Income

    -$369.60K
    NEUP annual net profit is -$369.60 thousand

    Net Margin

    -2.36%
    NEUP annual net profit margin is -2.36%

    Expenses

    Total Expenses

    $16.02M
    NEUP annual total expenses is $16.02 million

    Operating Expenses

    $16.12M
    NEUP annual total operating expenses is $16.12 million

    Cost Of Goods Sold

    $662.90K
    NEUP annual cost of goods sold is $662.90 thousand

    Selling, General & Administrative Expenses

    $0.00
    NEUP annual SG&A is $0.00

    Depreciation & Amortization

    $662.90K
    NEUP annual D&A is $662.90 thousand

    Interest Expense

    $0.00
    NEUP annual interest expense is $0.00

    Income Tax

    -$468.40K
    NEUP annual income tax is -$468.40 thousand

    EBIT & EBITDA

    EBIT

    -$1.13M
    NEUP annual earnings before interest & taxes is -$1.13 million

    EBITDA

    -$466.20K
    NEUP annual EBITDA is -$466.20 thousand

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $28.59M
    NEUP annual total assets is $28.59 million

    Non Current Assets

    $13.55M
    NEUP annual long term assets is $13.55 million

    Current Assets

    $15.04M
    NEUP annual total current assets is $15.04 million

    Cash and Cash Equivalents

    $14.29M
    NEUP annual cash & cash equivalents is $14.29 million

    Accounts Receivable

    -
    NEUP annual accounts receivable value is unknown

    Inventory

    $0.00
    NEUP annual inventory is $0.00

    Liabilities

    Total Liabilities

    $9.59M
    NEUP annual total liabilities is $9.59 million

    Long Term Liabilities

    $5.37M
    NEUP annual total long term liabilities is $5.37 million

    Current Liabilities

    $4.22M
    NEUP annual current liabilities is $4.22 million

    Accounts Payable

    $1.15M
    NEUP annual accounts payable is $1.15 million

    Debt

    Total Debt

    $149.10K
    NEUP annual total debt is $149.10 thousand

    Total Debt 1-Year Change

    -18.12%
    NEUP annual total debt is down -18.12% year-on-year

    Long Term Debt

    $0.00
    NEUP annual long term debt is $0.00

    Short Term Debt

    $149.10K
    NEUP annual short term debt is $149.10 thousand

    Equity & Capital

    Shareholders Equity

    $19.00M
    NEUP annual stockholders equity is $19.00 million

    Book Value

    $19.00M
    NEUP annual book value is $19.00 million

    Retained Earnings

    -$178.35M
    NEUP annual retained earnings is -$178.35 million

    Working Capital

    $10.82M
    NEUP annual working capital is $10.82 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $77.20K
    NEUP annual cash from operations is $77.20 thousand

    Cash From Operations 1-Year Change

    +100.8%
    NEUP annual cash from operations is up +100.8% year-on-year

    Cash From Investing

    $0.00
    NEUP annual cash from investing is $0.00

    Cash From Investing 1-Year Change

    0%
    NEUP annual cash from investing has remained unchanged year-on-year

    Cash From Financing

    $1.53M
    NEUP annual cash from financing is $1.53 million

    Cash From Financing 1-Year Change

    -84.56%
    NEUP annual cash from financing is down -84.56% year-on-year

    CAPEX

    CAPEX

    $0.00
    NEUP annual capital expenditures is $0.00

    CAPEX 1-Year Change

    0%
    NEUP annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free Cash Flow

    $77.20K
    NEUP annual free cash flow is $77.20 thousand

    Free Cash Flow 1-Year Change

    +100.8%
    NEUP annual free cash flow is up +100.8% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    95.76%
    NEUP annual gross profit margin is 95.76%

    Operating Margin

    -7.22%
    NEUP annual operating profit margin is -7.22%

    Net Margin

    -2.36%
    NEUP annual net profit margin is -2.36%

    ROA & ROE

    ROA

    -1.55%
    NEUP annual return on assets is -1.55%

    ROE

    -2.41%
    NEUP annual return on equity is -2.41%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    NEUP price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    NEUP price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    0.36
    NEUP price to book ratio is 0.36

    PB Ratio Sector Percentile

    23.55%
    NEUP price to book ratio is higher than 23.55% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    0.60
    NEUP price to sales ratio is 0.60

    PS Ratio Sector Percentile

    14.29%
    NEUP price to sales ratio is higher than 14.29% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    -$7.54M
    NEUP enterprise value is -$7.54 million

    Enterprise Value Sector Percentile

    5.17%
    NEUP enterprise value is higher than 5.17% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    66.46
    NEUP EV/EBITDA is 66.46

    EV/EBITDA Sector Percentile

    97.75%
    NEUP EV/EBITDA is higher than 97.75% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    3.56
    NEUP annual current ratio is 3.56

    Quick Ratio

    3.56
    NEUP annual quick ratio is 3.56

    Leverage

    Debt To Equity

    0.01
    NEUP annual debt to equity ratio is 0.01

    Interest Coverage Ratio

    -
    NEUP annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    NEUP piotroski f-score value is unknown

    Altman Z-Score

    -7.28
    NEUP altman z-score is -7.28

    Analyst ratings

    Recent major analysts updates

    Sep 11, 25 Maxim Group
    Buy
    Aug 26, 25 HC Wainwright & Co.
    Buy
    Feb 4, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with NEUP included

    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    High revenue growth stocks
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Neuphoria Therapeutics Inc.?
    • Does Neuphoria Therapeutics Inc. pay dividends?
    • What sector is Neuphoria Therapeutics Inc. in?
    • What industry is Neuphoria Therapeutics Inc. in?
    • What country is Neuphoria Therapeutics Inc. based in?
    • When did Neuphoria Therapeutics Inc. go public?
    • Is Neuphoria Therapeutics Inc. in the S&P 500?
    • Is Neuphoria Therapeutics Inc. in the NASDAQ 100?
    • Is Neuphoria Therapeutics Inc. in the Dow Jones?
    • When was Neuphoria Therapeutics Inc.'s last earnings report?
    • When does Neuphoria Therapeutics Inc. report earnings?

    What is the ticker symbol for Neuphoria Therapeutics Inc.?

    The ticker symbol for Neuphoria Therapeutics Inc. is NASDAQ:NEUP

    Does Neuphoria Therapeutics Inc. pay dividends?

    No, Neuphoria Therapeutics Inc. does not pay dividends

    What sector is Neuphoria Therapeutics Inc. in?

    Neuphoria Therapeutics Inc. is in the Healthcare sector

    What industry is Neuphoria Therapeutics Inc. in?

    Neuphoria Therapeutics Inc. is in the Biotechnology industry

    What country is Neuphoria Therapeutics Inc. based in?

    Neuphoria Therapeutics Inc. is headquartered in United States

    When did Neuphoria Therapeutics Inc. go public?

    Neuphoria Therapeutics Inc.'s initial public offering (IPO) was on December 16, 2021

    Is Neuphoria Therapeutics Inc. in the S&P 500?

    No, Neuphoria Therapeutics Inc. is not included in the S&P 500 index

    Is Neuphoria Therapeutics Inc. in the NASDAQ 100?

    No, Neuphoria Therapeutics Inc. is not included in the NASDAQ 100 index

    Is Neuphoria Therapeutics Inc. in the Dow Jones?

    No, Neuphoria Therapeutics Inc. is not included in the Dow Jones index

    When was Neuphoria Therapeutics Inc.'s last earnings report?

    Neuphoria Therapeutics Inc.'s most recent earnings report was on November 14, 2024

    When does Neuphoria Therapeutics Inc. report earnings?

    The next expected earnings date for Neuphoria Therapeutics Inc. is November 14, 2025
    On this page